We Are Discovering New Paths and Making Progress for the Future

About our scientific activities

Since the beginning of 2021., the organisational and strategy move was made in favour of stronger focus and company investment into internal R&D projects and own intellectual property. In line with that, Scientific Operations are organised within 3 important pillars: Research & development, Process development and Global regulatory affairs.

Our Areas of Expertise

Sterile solutions based on SW, MD category
Sterile ophthalmic drug solutions, with preservative
Sterile nasal solutions, PF-RX
Sterile ophthalmic solutions, PF-MD

Our New Targets

We believe in going beyond the products and technologies that we already acquired. Our new targets are innovative projects (both medical devices and pharmaceutical drugs) and complex technologies (e.g. nano – emulsions, suspensions) with continued focus on offering solutions for eye, nose and skin therapy.

Integra

Explore Integra, our investment and development project.

Find out more

Do you want to work with us?

Our people are our key strength. We are building internal talents and searching for experts who are familiar with:

Complex Pharmaceutical Technologies and Products Development
Extended pharmaceutical equivalence/analytical
Creative clinical strategies
In vitro-in vivo correlations
Innovative and proactive IP strategies

Explore what is work at JGL like

2 min 05.12.2024.

JGL’s sustainability-linked bonds listed

The issue, with a total nominal value of EUR 60 million and a fixed annual interest rate of 4.125%, underscores JGL’s significant role as an issuer driving the development of the domestic capital market.

1 min 29.11.2024.

Eva Usmiani Capobianco at Conference on Internationalisation

The Croatian Chamber of Economy hosted the 2nd Internationalisation Conference in Zagreb on 26 November 2024 to emphasise the vital role of exporters in the economic system and support companies in international markets.

1 min 27.11.2024.

Highly Successful Placement of JGL Bonds on the Domestic Capital Market

We are proud to announce the successful completion of JGL’s latest bond issue. The strong interest and favourable final terms achieved are a testament to JGL’s credibility as a trusted issuer in the domestic capital market and reflect investor confidence in our strategic direction and dynamic growth over recent years.

1 min 22.11.2024.

JGL Representatives Met With the Deputy Prime Minister of Kazakhstan

Kazakhstan’s Deputy Prime Minister and Minister of Foreign Affairs, Murat Nurtleu, met with representatives of top Croatian companies during his official visit to Croatia.